SCHEMBL1171650

SCHEMBL1171650

O=C(O)c1cc2occc2[nH]1.[NaH]

nearest known ligand 0.96

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 6/20 0.96
▸ KDM4E B2RXH2 4/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ MAPT P10636 1/20 0.46
▸ SRD5A2 P31213 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ SMAD3 P84022 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ GPR35 Q9HC97 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ NFKB1 P19838 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ F7 P08709 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ PIN1 Q13526 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679809 0.98 DAO (1.00) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL12864422 0.81 DAO (0.71) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL12864395 0.81 DAO (0.71) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL1171052 0.81 DAO (0.71) DAOPOLBGAA
SCHEMBL1171400 0.81 DAO (0.71) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL12864371 0.80 DAO (0.69) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL1171150 0.80 DAO (0.69) DAOKDM4EHSD17B10HPGDMAPT
SCHEMBL12904066 0.79 DAO (0.67) DAOKDM4EPOLBALDH1A1GAA
SCHEMBL12864593 0.77 DAO (0.65) DAOKDM4EPOLBGAALMNA
SCHEMBL2406834 0.77 DAO (0.65) DAOPOLBGAAKMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110034434-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-02-10 — — US disclosed
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-05-13 — — US disclosed
WO-2010017418-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 DAO 2/4885KDM4E 2574/4885HSD17B10 1406/4885
US-20110034434-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 DAO 2/4885KDM4E 2574/4885HSD17B10 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback